Certain studies support our hypothesis, anti‐PD‐L1 could augment the antitumor activity of tumor‐directed immunocytes in inhibiting tumor growth.24, 25 Schuster et al reported a refractory DLBCL patient of primary mediastinal origin with extra‐nodal involvement of small intestine. The gene discussed is CD274; the disease is neoplasm.